[Effect of metabolic inhibitors on glucolysis and osmotic fragility of human erythrocytes].
D000963:Antimetabolites / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D007461:Iodoacetates / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D009996:Osmotic Fragility / Q000187:drug effects*; D012964:Sodium / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology
D000963:Antimetabolites; D007461:Iodoacetates; D009578:Nitrobenzenes; D005461:Fluorine; D012965:Sodium Chloride; D012964:Sodium; D005947:Glucose; D005459:Fluorides
Acción de inhibidores metabólicos sobre la glucolisis y fragilidad osmótica de eritrocitos humanos.